Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer
We are thrilled to welcome Jeff to our executive team," said
About Dignify Therapeutics
Founded by a team of serial entrepreneurs who are internationally recognized scientists, Dignify Therapeutics' mission is to provide practical and convenient treatments for bladder and bowel voiding dysfunctions, primarily using a repositioning strategy of drug discovery that the team has successfully implemented multiple times over the last 20 years in the fields of urology and gastroenterology.
The Company is funded by founders, venture capital firms (RA Capital Management and Eshelman Ventures), the North Carolina Biotechnology Center, the One NC Small Business Program, and the NIH SBIR/STTR program (with 18 awards and approximately
View original content to download multimedia:https://www.prnewswire.com/news-releases/dignify-therapeutics-announces-jeff-welch-as-chief-operating-officer-302480520.html
SOURCE Dignify Therapeutics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MARS Company Named to the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
- BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions
- TSA Administrator David P. Cummins launches Horizon 25 Strategy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
RA Capital, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share